Pseudomonas aeruginosa Lipid A Structural Variants Induce Altered Immune Responses

Area of Science:

• Microbiology
• Immunology
• Pulmonology

Background:

• *Pseudomonas aeruginosa* is a major cause of chronic lung infections in cystic fibrosis (CF) patients, leading to lung damage.
• *P. aeruginosa* adapts to the CF lung environment, altering its outer membrane component, lipid A.
• Lipid A is a key component of endotoxin and a potent activator of Toll-like receptor 4 (TLR4), influencing immune responses.

Purpose of the Study:

• To investigate the structural modifications of *P. aeruginosa* lipid A during chronic CF lung infection.
• To determine the impact of these lipid A alterations on host immune responses, specifically cytokine production.
• To explore the role of PagL-mediated deacylation and 2-hydroxylation in CF lung infections.

Main Methods:

• Direct-from-sample mass spectrometry analysis of human bronchoalveolar lavage (BAL) fluid.
• In vitro studies using primary human macrophages and bronchial epithelial cells.
• Assessment of cytokine secretion (e.g., IL-8) and TLR4 signaling.

Main Results:

• *P. aeruginosa* lipid A in CF airways lacks PagL-mediated deacylation.
• This modified lipid A structure induces increased proinflammatory cytokine production by macrophages.
• Alterations in lipid A 2-hydroxylation affect cytokine response, and a CF-specific reduction in IL-8 secretion was observed in epithelial cells.

Conclusions:

• *P. aeruginosa* undergoes significant lipid A structural changes during CF lung infections.
• The CF-adapted lipid A structure potentiates TLR4 signaling, contributing to heightened inflammation.
• These findings highlight a novel mechanism of immune evasion and persistence by *P. aeruginosa* in the CF lung.